Document is current
Any future updates will be listed below
-
Authors
Zhang, Yang https://orcid.org/0000-0001-9831-7687
Liu, Gan https://orcid.org/0000-0001-5170-2537
Tao, Minzhen https://orcid.org/0000-0002-0575-6224
Ning, Hui
Guo, Wei
Yin, Gaofei
Gao, Wen
Feng, Lifei https://orcid.org/0009-0004-7775-6209
Gu, Jin https://orcid.org/0000-0003-3968-8036
Xie, Zhen https://orcid.org/0000-0001-8798-9592
Huang, Zhigang https://orcid.org/0000-0002-4102-9278
- License Information
-
More Information
Article History
Received: 29 April 2022
Accepted: 3 March 2023
First Online: 16 March 2023
Competing interests
: Two patents based on the study were submitted by Z.X., Y.Z., G.L., and M.T., which were entitled as “Featured gene sets based on scRNA-seq profiles of malignant tumor cells for the prognosis prediction of hypopharyngeal carcinoma” (application number, no 202310103758.7) and “A prediction method of the therapeutic efficacy for the combined treatment in advanced hypopharyngeal carcinoma based on the integration of single-cell and bulk transcriptome profiles” (application number, no 202310106947.X). The remaining authors declare no competing interests.
